Stem Cells as an Enabling Technology in Drug Discovery Stem cells (SCs) are emerging as a viable enabling technology for high
throughput screening and lead discovery, and the replacement of mouse
SCs with a reliable commercial source of large quantities of reproducible
human SC populations will offer a major opportunity to improve the
clinical predictability of preclinical drug discovery and development. By Maria Webb at Ligand Pharmaceuticals (December 2009)
Keywords: stem cells, screening, lead discovery, webb, ligand pharmaceuticals,
|
